Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study

類似資料

• Efficacy and safety of tofacitinib as monotherapy in Japanese patients with active rheumatoid arthritis: a 12-week, randomized, phase 2 study
  著者:: Tanaka, Yoshiya, 等
  出版事項: (2015)
• Modified- versus immediate-release tofacitinib in Japanese rheumatoid arthritis patients: a randomized, phase III, non-inferiority study
  著者:: Tanaka, Yoshiya, 等
  出版事項: (2019)
• Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials
  著者:: Takeuchi, Tsutomu, 等
  出版事項: (2015)
• Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis
  著者:: Fleischmann, Roy M, 等
  出版事項: (2016)
• Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate
  著者:: O’Mahony, Alison, 等
  出版事項: (2018)